Openings in Eli Lilly for Intern in Clinical Surveillance Scientist

Openings in Eli Lilly for Intern in Clinical Surveillance Scientist

 

Eli Lilly Logo




About the Job 

The firm have more than 10000+ employees and is founded in 1876 and have offices more than 18 countries. The firm have head quarters in Indiana polis. The firm have more than 145 year of excellence and have expert medical professionals with the core values in integrity, excellence and respect for people. During the pandemic times it involved in delivering Covid medicines.  The firm have a Nobel prize awarded at 1928 with the liver extract for anemia. The company have many block buster molecules like Cymbalta and have scope of large and small molecular development. The firm have oncology division specialized in delivering world class medicines. 

About the Job 

Location : Bangalore 

Need to have degree in pharma (PharmD) or nursing with advanced clinical specialization like Nurse practitioner. or Masters in Health care or Life sciences

Responsibility 


Required to collect and perform the data acquisition strategy, methodology, and approach for safety and related evaluations. Timely handling and able to Perform analysis of safety data and lead authoring of safety topic reports

Required to communicate relevant safety information to the respective core team, business partners, and key stakeholders in a timely manner.

Need to co ordinate and interact with safety physicians, medical directors, pharmaco-epidemiologists, and other personnel as required and needed to be appropriate to ensure thorough evaluation and aggregate analysis of safety data, demonstrating the ability to understand and communicate scientific issues and strategy

Need to have the judgment based decision making principles to contribute to key scientific/clinical discussions

Develop and review label changes and labelling modifications in collaboration with teams, regulatory and legal.

Should be able to perform the Identification, analysis, and evaluation of safety signals that arise from multiple internal and external data sources to determine signals or risks that could result in changes to labels and/or benefit-risk profile and consult and collaborate with other safety personnel as appropriate.

Taking the effective communication skills to lead and facilitate safety team meetings for compounds in clinical development and marketed products